Clinical News and Research

RSS

RNA sequencing picks up more genetic changes in pediatric cancer patients than traditional tests

Analysis of the entire tumor RNA picks up more clinically relevant genetic changes in children with cancer than traditional diagnostic methods, new research has shown.

28 Jan 2022

An Interview with The Million Veteran Program (MVP)

In this interview, we speak to Dr. Sumitra Muralidhar, the Program Director for VA’s Million Veteran Program (MVP) about the program and its aims for veterans.

28 Jan 2022

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

We speak to Dr. Chao Ma, one of the speakers at SLAS 2022, about his groundbreaking 'leukemia-on-a-chip' technology and its future within therapy resistance.

From Society for Laboratory Automation and Screening (SLAS) 27 Jan 2022

Study investigates the proteins influencing the aging process

Scientists identified two blood proteins that positively influence human health and lifespan.

27 Jan 2022

Culturing marine sponge cells in 3D could scale-up production of biomass, bioactive metabolites

There are more than 9,000 species of marine sponges (Phylum Porifera) worldwide, which are a source of novel natural products.

25 Jan 2022

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

25 Jan 2022

Producing New Antibiotics Through Gene Editing

In this interview, we speak to Professor Jason Micklefield about his latest research that may be able to produce new antibiotics through gene-editing technologies.

From The University of Manchester 24 Jan 2022

IL-6 regulates cartilage regeneration in joints and growth plates, says study

The IL-6 protein family has a poor reputation for promoting inflammation, arthritis, autoimmune disease, and even cancer.

20 Jan 2022

Virologists identify a dual-action drug effective against SARS-CoV-2

A research team discovered a new dual attack mode of action while working on the development of a therapeutic candidate against SARS-CoV-2 infections.

20 Jan 2022

Coffee found to have a stimulating effect on some digestive processes

A new scientific review, published in Nutrients, highlights coffee's effects on digestion and the gut, and its impact on organs involved in digestion.

19 Jan 2022

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical computing.

From TetraScience, Inc. 18 Jan 2022

Daily consumption of more olive oil linked to lower mortality risk

Consuming more than 7 grams (>1/2 tablespoon) of olive oil per day is associated with lower risk of cardiovascular disease mortality, cancer mortality, neurodegenerative disease mortality and respiratory disease mortality, according to a study publishing today in the Journal of the American College of Cardiology.

17 Jan 2022

Researchers discover a gene variant that protects against severe COVID-19 infection

An international metastudy led by researchers at Karolinska Institute in Sweden has identified a specific gene variant that protects against severe COVID-19 infection.

17 Jan 2022

Researchers identify new potential drug target that may block SARS-CoV-2 infection

In the quest for new treatments for COVID-19, a team led by researchers at UC San Francisco has identified a new potential drug target that may block infection by SARS-CoV-2. The protein, called BRD2, regulates the ACE2 receptor, which the novel coronavirus relies on to gain entry to its host's cells.

17 Jan 2022

Researchers conduct genome sequencing studies in children with in-born immunity disorders

The Sanford Children’s Genomic Medicine Consortium has ten hospitals collaborating for whole genome sequencing studies on patients with suspected inborn immunity disorders (IEI).

13 Jan 2022

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company today announced the expansion of its norovirus-like particle range, with the addition of six new reagents.

From The Native Antigen Company 13 Jan 2022

New 'disease-in-a-dish' system developed to study oculocutaneous albinism

Researchers at the National Eye Institute have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA).

12 Jan 2022

Research explains how E4 peptide exerts antifibrotic effect and what makes it so effective

A research team at the Medical University of South Carolina led by Carol Feghali-Bostwick, Ph.D., reports in the Journal of Clinical Investigation Insight that the E4 peptide reverses fibrosis, or scarring, in human and mouse tissues by activating an antifibrotic pathway that is common to all organ systems.

11 Jan 2022

Neurons derived from human stem cells can predict the cardinal features of psychiatric illness

In a breakthrough that holds significant promise for early diagnosis and better treatment of psychiatric illness, researchers have for the first time used neurons derived from human stem cells to predict the cardinal features of a psychiatric illness, such as psychosis and cognitive deficits in patients with schizophrenia.

11 Jan 2022

Scientists develop molecules for myocardial PET and fluorescence bimodal imaging

Heart disease continues to be a leading cause of mortality and morbidity across the globe. Positron emission tomography (PET) has slowly become a remarkable technology of a non-invasive technique for accurately diagnosing cardiac diseases.

11 Jan 2022

Clinical News and Research

RNA sequencing picks up more genetic changes in pediatric cancer patients than traditional tests

An Interview with The Million Veteran Program (MVP)

Leukemia-on-a-chip; The Future of Preventing Therapy Resistance?

Study investigates the proteins influencing the aging process

Culturing marine sponge cells in 3D could scale-up production of biomass, bioactive metabolites

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Producing New Antibiotics Through Gene Editing

IL-6 regulates cartilage regeneration in joints and growth plates, says study

Virologists identify a dual-action drug effective against SARS-CoV-2

Coffee found to have a stimulating effect on some digestive processes

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

Daily consumption of more olive oil linked to lower mortality risk

Researchers discover a gene variant that protects against severe COVID-19 infection

Researchers identify new potential drug target that may block SARS-CoV-2 infection

Researchers conduct genome sequencing studies in children with in-born immunity disorders

The Native Antigen Company Expands Range of Norovirus-Like Particles

New 'disease-in-a-dish' system developed to study oculocutaneous albinism

Research explains how E4 peptide exerts antifibrotic effect and what makes it so effective

Neurons derived from human stem cells can predict the cardinal features of psychiatric illness

Scientists develop molecules for myocardial PET and fluorescence bimodal imaging

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics